Monday, June 18 10:00 am – 1:00 pm
SC1: Introduction to GPCR-Based Drug Discovery - Detailed Agenda (Staffordshire)
Annette Gilchrist, PhD, Professor, Pharmacology, Midwestern University
Monday, June 18 2:30 – 5:30 pm
SC3: Drug Metabolism and Its Impact on Decisions in Lead Discovery and Drug Development - Detailed Agenda (Staffordshire)
Donglu Zhang, PhD, Senior Scientist, Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.
Zhengyin Yan, PhD, Senior Scientist, Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.
David Duignan, PhD, Principal Research Scientist, Drug Metabolism, Pharmacokinetics & Bioanalysis, AbbVie Bioresearch Center
SC4: Practical Phenotypic Screening - Detailed Agenda (Essex North)
Fabien Vincent, PhD, Associate Research Fellow, Hit Discovery and Lead Profiling Group, Pfizer
SC6: Collecting, Storing, and Utilizing Precious Patient-Derived Tumors for Drug Discovery and Development - Detailed Agenda (St. George CD)
Mark A. Murakami, MD, Instructor in Medicine, Department of Medical Oncology, Dana-Farber Cancer Institute
Srivatsan Raghavan, MD, PhD, Instructor, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute
SC7: Introduction to Nanoparticles and Extracellular Vesicles for Drug Delivery - Detailed Agenda (St. George AB)
Hicham Fenniri, PhD, Professor, Chemical and Biomedical Engineering, Northeastern University
Additional Instructors to be Announced
Monday, June 18 6:00 – 9:00 pm (Dinner Provided)
SC9: How to Best Utilize 3D Cells, Spheroids, PDX Models in Oncology - Detailed Agenda (St. George AB)
Madhu Lal-Nag, PhD, Group Leader, Trans-NIH RNAi Facility, National Center for Advancing Translational Sciences, National Institutes of Health
Geoffrey Bartholomeusz, PhD, Associate Professor and Director, Target Identification and Validation Program, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
SC10: Applications of Artificial Intelligence & Machine Learning in Drug Discovery & Development - Detailed Agenda (Staffordshire)
Arvind Rao, PhD, Associate Professor, Department of Computational Medicine and Bioinformatics, University of Michigan
Istvan Enyedy, PhD, Principal Scientist, Medicinal Chemistry, Biogen
Jin Yao, Ph.D., Scientific Investigator, Computational Biology and Statistics, Target Sciences, GlaxoSmithKline
Ronald Alfa, MD, PhD, Vice President, Discovery & Product, Recursion Pharmaceuticals
SC11: Understanding and Dealing with Drug Disposition in CNS - Detailed Agenda (St. George CD)
Qin Wang, PhD, Principal Scientist, Drug Metabolism and Pharmacokinetics, Biotherapeutics and Medicinal Sciences, Biogen, Inc.
Wednesday, June 20 6:30 – 9:30 pm (Dinner Provided)
SC12: Humanized Mouse Models for Preclinical Assessment of Cancer Immunotherapy - Detailed Agenda (Empire)
Barbara Joyce-Shaikh, Associate Principal Scientist, Merck Research Laboratories
Maria Pinzon-Ortiz, Scientific Technical Leader, Immuno Oncology (In vivo), Novartis
SC14: Advanced Bioprinting Strategies for Generation of 3D Tissue Models - Detailed Agenda (Defender)
Margaret Prendergast, Director, Bioengineering, Allevi, Inc.
Ricky Solorzano, CEO, Allevi, Inc.
Yu Shrike Zhang, PhD, Research Faculty & Associate Bioengineer, Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School & Harvard-MIT Division of Health Sciences and Technology
SC15: Evaluating and Characterizing in vitro Models of Drug Toxicity - Detailed Agenda (Great Republic)
Terry Van Vleet, PhD, DABT, Head of Molecular and Computational Toxicology, Department of Preclinical Safety, Abbvie
Will Proctor, PhD, Senior Scientist, Head of Investigative Toxicology, Department of Safety Assessment, Genentech
SC16: Applications of CRISPR and Single-Cells: Best Practices from Set-Up to Data Analysis - Detailed Agenda (Helicon)
Stephanie Mohr, PhD, Lecturer, Genetics & Director, Drosophila RNAi Screening Center at Harvard Medical School
Jennifer Smith, PhD, Deputy Director, ICCB-Longwood Screening Facility, Harvard Medical School
Sarah Boswell, PhD, Director of Sequencing Technologies, Laboratory of Systems Pharmacology and Director, Single-Cell Sequencing Core, Harvard Medical School
Roderick Beijersbergen, PhD, Group Leader, Netherlands Cancer Institute and Head, NKI Robotics and Screening Center
*Separate registration required for Short Courses.